Tirzepatide emerges as first drug therapy for obstructive sleep apnea

Researchers at University of California San Diego School of Medicine and international collaborators have led a worldwide, advanced study demonstrating the potential of tirzepatide, known to manage type 2 diabetes, as the first effective drug therapy for obstructive sleep apnea (OSA), a sleep-related disorder characterized by repeated episodes of irregular breathing due to complete or partial blockage of the upper airway.

Scientists find first drug to treat sleep apnea

knowridge.com - 23/Jun 10:25

In recent research led by the University of California San Diego School of Medicine, scientists have found a new potential treatment for obstructive...

GLP-1 Medicine Mounjaro May Be First Drug to Ease Sleep Apnea

drugs.com - 21/Jun 20:25

FRIDAY, June 21, 2024 -- A medication used to manage type 2 diabetes has been found effective in treating sleep apnea.The worldwide clinical trial...

ADA: Tirzepatide Reduces Apnea-Hypopnea Index in Moderate-to-Severe OSA

drugs.com - 26/Jun 15:06

WEDNESDAY, June 26, 2024 -- Tirzepatide reduces the apnea-hypopnea index (AHI) among individuals with moderate-to-severe obstructive sleep apnea and...

Weight-Loss Drug Zepbound Offers a New Way to Treat Sleep Apnea

the new york times - 21/Jun 20:20

New research showed that tirzepatide, the compound in Zepbound, improved symptoms of obstructive sleep apnea.

Is Eli Lilly (LLY) a Buy on Tirzepatide Success in Sleep Apnea?

zacks.com - 25/Jun 13:05

Eli Lilly (LLY) files for the approval of tirzepatide to treat obstructive sleep apnea in adults with obesity in the United States. If approved, sales...

Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year

asianewsday.com - 21/Jun 20:29

Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related breathing...

Weight loss drug could ease sleep apnoea in people with obesity, study says

theguardian.com - 21/Jun 19:45

Research raises possibility that tirzepatide could become first pharmaceutical treatment for the sleeping disorder

Why some people stop breathing at night

knowridge.com - 18/Jun 00:14

Sleep apnea is a common but serious disorder where breathing repeatedly stops and starts during sleep. This condition can lead to daily fatigue,...

Bariatric Surgery Tied to Lower Risk of MACE, Death in Obesity, Sleep Apnea

drugs.com - 28/Jun 15:03

FRIDAY, June 28, 2024 -- Metabolic surgery is associated with significantly lower risk of major adverse cardiovascular events (MACE) compared with...

Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA

varabnewsexpress.ae - 06:10

Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA Mont-Saint-Guibert (Belgium), July 1, 2024, 8:00am CET / 2:00am...

Rubriques :